184 related articles for article (PubMed ID: 32980421)
1. Clinical treatment options for early-stage and advanced conjunctival melanoma.
Zeng Y; Hu C; Shu L; Pan Y; Zhao L; Pu X; Wu F
Surv Ophthalmol; 2021; 66(3):461-470. PubMed ID: 32980421
[TBL] [Abstract][Full Text] [Related]
2. Conjunctival Melanoma: Current Treatments and Future Options.
Grimes JM; Shah NV; Samie FH; Carvajal RD; Marr BP
Am J Clin Dermatol; 2020 Jun; 21(3):371-381. PubMed ID: 31965542
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
Larsen AC
Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
[TBL] [Abstract][Full Text] [Related]
4. New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.
Peil J; Bock F; Kiefer F; Schmidt R; Heindl LM; Cursiefen C; Schlereth SL
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163401
[TBL] [Abstract][Full Text] [Related]
5. Genetic characterization of advanced conjunctival melanoma and response to systemic treatment.
Lodde GC; Jansen P; Möller I; Sucker A; Hassel JC; Forschner A; Eckardt J; Meier F; Reinhardt L; Kähler KC; Ziemer M; Schlaak M; Rahimi F; Schatton K; Meiss F; Gutzmer R; Pföhler C; Terheyden P; Schilling B; Sachse M; Heppt MV; Sindrilaru A; Leiter U; Zaremba A; Thielmann CM; Ugurel S; Zimmer L; Hadaschik E; Bechrakis NE; Schadendorf D; Westekemper H; Livingstone E; Griewank KG;
Eur J Cancer; 2022 May; 166():60-72. PubMed ID: 35279471
[TBL] [Abstract][Full Text] [Related]
6. [Adjuvant therapy and interdisciplinary follow-up care of conjunctival melanoma].
Heindl LM; Koch KR; Schlaak M; Mauch C; Cursiefen C
Ophthalmologe; 2015 Nov; 112(11):907-11. PubMed ID: 26502167
[TBL] [Abstract][Full Text] [Related]
7. Integrative Exome and Transcriptome Analysis of Conjunctival Melanoma and Its Potential Application for Personalized Therapy.
Demirci H; Demirci FY; Ciftci S; Elner VM; Wu YM; Ning Y; Chinnaiyan A; Robinson DR
JAMA Ophthalmol; 2019 Dec; 137(12):1444-1448. PubMed ID: 31647501
[TBL] [Abstract][Full Text] [Related]
8. [Pathology and prognostic factors of conjunctival melanoma].
Berta-Antalics AI; Kruse FE; Holbach L
Ophthalmologe; 2015 Nov; 112(11):892, 894-8. PubMed ID: 26531292
[TBL] [Abstract][Full Text] [Related]
9. Conjunctival Melanoma: Update on Genetics, Epigenetics and Targeted Molecular and Immune-Based Therapies.
Gkiala A; Palioura S
Clin Ophthalmol; 2020; 14():3137-3152. PubMed ID: 33116365
[TBL] [Abstract][Full Text] [Related]
10. Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
Cid-Bertomeu P; Huerva V
Surv Ophthalmol; 2022; 67(5):1391-1404. PubMed ID: 35278438
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of patients with conjunctival melanoma.
Werschnik C; Lommatzsch PK
Am J Clin Oncol; 2002 Jun; 25(3):248-55. PubMed ID: 12040282
[TBL] [Abstract][Full Text] [Related]
12. Two cases of BRAF-mutated, bulbar conjunctival melanoma, and review of the published literature.
Kiyohara T; Tanimura H; Miyamoto M; Shijimaya T; Nagano N; Nakamaru S; Makimura K; Iwai H
Clin Exp Dermatol; 2020 Mar; 45(2):207-211. PubMed ID: 31361915
[TBL] [Abstract][Full Text] [Related]
13. A Retrospective Review of Conjunctival Melanoma Presentation, Treatment, and Outcome and an Investigation of Features Associated With BRAF Mutations.
Larsen AC; Dahmcke CM; Dahl C; Siersma VD; Toft PB; Coupland SE; Prause JU; Guldberg P; Heegaard S
JAMA Ophthalmol; 2015 Nov; 133(11):1295-303. PubMed ID: 26425792
[TBL] [Abstract][Full Text] [Related]
14. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
Lommatzsch PK; Werschnik C
Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Griewank KG; Westekemper H; Murali R; Mach M; Schilling B; Wiesner T; Schimming T; Livingstone E; Sucker A; Grabellus F; Metz C; Süsskind D; Hillen U; Speicher MR; Woodman SE; Steuhl KP; Schadendorf D
Clin Cancer Res; 2013 Jun; 19(12):3143-52. PubMed ID: 23633454
[TBL] [Abstract][Full Text] [Related]
16. Clinical Management of Uveal and Conjunctival Melanoma.
Blum ES; Yang J; Komatsubara KM; Carvajal RD
Oncology (Williston Park); 2016 Jan; 30(1):29-32, 34-43, 48. PubMed ID: 26791842
[TBL] [Abstract][Full Text] [Related]
17. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
[TBL] [Abstract][Full Text] [Related]
18. Treatment response and recurrence of conjunctival melanoma with orbital invasion treated with immune checkpoint inhibitors: case report and literature review.
Alhammad FA; Alburayk KB; Albadri KS; Butt SA; Azam F
Orbit; 2024 Feb; 43(1):49-57. PubMed ID: 37052129
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival melanoma treatment outcomes in 288 patients: a multicentre international data-sharing study.
Jain P; Finger PT; Fili M; Damato B; Coupland SE; Heimann H; Kenawy N; J Brouwer N; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
Br J Ophthalmol; 2021 Oct; 105(10):1358-1364. PubMed ID: 32892167
[TBL] [Abstract][Full Text] [Related]
20. Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series.
Finger PT; Pavlick AC
J Immunother Cancer; 2019 Mar; 7(1):83. PubMed ID: 30909967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
